Biotech

All Articles

Lykos are going to talk to FDA to reevaluate its selection complying with rejection of MDMA therapy for post-traumatic stress disorder

.Adhering to a poor revealing for Lykos Therapeutics' MDMA prospect for trauma at a recent FDA advis...

AN 2 one-halfs roll call, stops stage 3 test after data disappoint

.AN2 Therapies is actually reviewing its business in action to dull midphase records, vowing to lay ...

Merck spends $700M for bispecific, spying autoimmune position and also chance to test Amgen in cancer

.Merck &amp Co. is paying for $700 thousand beforehand to challenge Amgen in a blood cancer market. ...

Gilead pays out J&ampJ $320M to exit licensing offer for seladelpar

.With Gilead Sciences about to an FDA choice for its own liver health condition medication seladelpa...

' All palms on deck' at Lilly as peers target obesity market

.CEO David Ricks can observe the firms establishing camping tents at basecamp responsible for Eli Li...

Entero laying off workers, leaving workplace and pausing R&ampD

.Bed Liquidators has actually turned Entero Therapies white colored as a piece. The collector got En...

Exelixis falls ADC after determining it's no match for Tivdak

.Exelixis is losing hope on its tissue variable (TF)- targeting antibody-drug conjugate after ending...

Relay loses interest in SHP2 prevention after Genentech leaves behind

.Three full weeks after Roche's Genentech device left an SHP2 inhibitor deal, Relay Rehab has actual...

Stoke's Dravet disorder med launched of partial professional grip

.Stoke Therapies' Dravet disorder drug has actually been without a predisposed hold, clearing the me...

Fierce Biotech's Gabrielle Masson presents Strong 15 at NYSE

.Fierce Biotech Associate Publisher Gabrielle Masson showed the 2024 lesson of Ferocious 15 champion...